Instant View: S&P rises above 3,000 level for first time since March

Instant View: S&P rises above 3,000 level for first time since March
(Reuters) – U.S. stocks rose above the 3,000 level for the first time since March 5 on Tuesday, continuing a rally that has pushed the benchmark index up nearly 35% from its March 23 closing low on hopes for a potential coronavirus vaccine and the reopening of businesses across the country. Traders with masks work on the first day of... Read More

Wall Street set to surge at open on recovery, vaccine hopes

Wall Street set to surge at open on recovery, vaccine hopes
(Reuters) – Wall Street was set to surge at the open, with the S&P 500 poised to breach a major technical barrier on Tuesday as business restarts and optimism about a potential coronavirus vaccine helped investors overlook Sino-U.S. tensions. Traders work inside posts, on the first day of in-person trading since the closure during the coronavirus disease (COVID-19) outbreak on... Read More

S&P 500 futures surge on recovery, vaccine hopes

S&P 500 futures surge on recovery, vaccine hopes
(Reuters) – U.S. stock futures surged on Tuesday as business restarts and optimism about a potential coronavirus vaccine helped investors returning from a long weekend to overlook Sino-U.S. tensions. FILE PHOTO: A nearly empty trading floor is seen as preparations are made for the return to trading at the New York Stock Exchange (NYSE) in New York, U.S., May 22,... Read More

Take Five: Coronavirus vaccine race is on

Take Five: Coronavirus vaccine race is on
(Reuters) – 1/VACCINE RACE FILE PHOTO: Passersby wearing protective face masks following an outbreak of the coronavirus disease (COVID-19) are reflected on a screen displaying stock prices outside a brokerage in Tokyo, Japan, March 17, 2020. REUTERS/Issei Kato U.S. President Donald Trump has put his faith in anti-malarial drug hydroxychloroquine to ward off COVID-19, but governments and investors are focusing... Read More

Germany approves new powers to block foreign takeovers in healthcare

Germany approves new powers to block foreign takeovers in healthcare
FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski (Reuters) – Germany gave itself new powers to veto hostile foreign takeover bids for healthcare companies on Wednesday, a measure designed to ensure a continuous supply of essential products during the coronavirus crisis. The regulation, approved by the cabinet, will allow the... Read More

Early data on Moderna’s COVID-19 vaccine insufficient: Stat News

Early data on Moderna’s COVID-19 vaccine insufficient: Stat News
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder (Reuters) – Data from a small, early-stage safety trial testing Moderna Inc’s (MRNA.O) experimental COVID-19 vaccine does not provide critical data to assess its effectiveness, Stat News reported on Tuesday, citing experts. The... Read More

Coronavirus vaccine from Moderna appears safe, shows promise in data from eight people

Coronavirus vaccine from Moderna appears safe, shows promise in data from eight people
(Reuters) – Moderna Inc’s (MRNA.O) experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by the biotech company on Monday. The data comes from eight people who took part in a 45-subject safety trial that kicked off in March. The Moderna... Read More

Trump to tap ex-Glaxo exec, U.S. general for coronavirus vaccine effort

Trump to tap ex-Glaxo exec, U.S. general for coronavirus vaccine effort
FILE PHOTO: U.S. President Donald Trump speaks during a coronavirus disease (COVID-19) outbreak response press briefing in the Rose Garden of the White House in Washington, U.S., May 11, 2020. REUTERS/Kevin Lamarque WASHINGTON (Reuters) – President Donald Trump is expected to tap a former GlaxoSmithKline executive and a U.S. general to spearhead the government’s effort at developing a coronavirus vaccine... Read More

Pfizer to outsource some drug production, focus on coronavirus vaccine

Pfizer to outsource some drug production, focus on coronavirus vaccine
(Reuters) – Pfizer Inc (PFE.N) said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective. FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October... Read More